Evidence map›Paper›PMID 34022218›Full record

ArticleThe Journal of biological chemistry2021

Excess exogenous pyruvate inhibits lactate dehydrogenase activity in live cells in an MCT1-dependent manner.

Yi Rao, Seth T Gammon, Margie N Sutton, Niki M Zacharias, Pratip Bhattacharya, David Piwnica-Worms

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Hyperpolarized [1-Magnetic resonance in medicine · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Comparative genomic analysis ofFrontiers in microbiology · 2022
    Article
  19. Review
  20. HSA-miR-34a-5p regulates the SIRT1/TP53 axis in prostate cancer.American journal of translational research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yi RaoDepartment of Cancer System Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Seth T GammonDepartment of Cancer System Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Margie N SuttonDepartment of Cancer System Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Niki M ZachariasDepartment of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Pratip BhattacharyaDepartment of Cancer System Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
David Piwnica-WormsDepartment of Cancer System Imaging, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. Electronic address: dpiwnica-worms@mdanderson.org.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
WU-MDACC Inter-Institutional Molecular Imaging CenterP50CA094056 · NCI · WASHINGTON UNIVERSITY · PI PIWNICA-WORMS, DAVID · 2002 to 2016
$26.3M
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic CancerP50CA221707 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KOPETZ, SCOTT, MAITRA, ANIRBAN · 2019 to 2023
$11.0M
Circulating Biomarkers and Imaging for Early Detection of Pancreatic CancerU01CA214263 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI EUGENE J KOAY, Subrata Sen · 2018 to 2026
$7.2M
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and CancerR01CA218004 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MAITRA, ANIRBAN · 2018 to 2021
$2.4M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA094056NCI NIH HHS P50 CA221707NCI NIH HHS R01 CA218004NCI NIH HHS U01 CA214263
6 · The paper itself

Abstract

Cellular pyruvate is an essential metabolite at the crossroads of glycolysis and oxidative phosphorylation, capable of supporting fermentative glycolysis by reduction to lactate mediated by lactate dehydrogenase (LDH) among other functions. Several inherited diseases of mitochondrial metabolism impact extracellular (plasma) pyruvate concentrations, and [1-

Indexed as

AcidsBuffersCarbon IsotopesCell ExtractsCell Line, TumorCell MembraneExtracellular SpaceGlycolysisHumansInhibitory Concentration 50KineticsLactic AcidL-Lactate DehydrogenaseMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersPyruvic AcidAcidsBuffersCarbon-13Carbon IsotopesCell ExtractsLactic AcidL-Lactate DehydrogenaseMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersPyruvic AcidSymporters[1-(13)C]pyruvate(13)C magnetic resonance spectroscopycancer metabolismhyperpolarized (13)Clactate dehydrogenaseLDHMRSIstable isotope

Identifiers

PMID34022218
PMCPMC8233206
OpenAlexW3164841893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.